| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sirtuin 3 | 21 | 2022 | 34 | 4.090 |
Why?
|
| Adipocytes | 15 | 2020 | 158 | 2.800 |
Why?
|
| Neuroblastoma | 2 | 2023 | 511 | 1.220 |
Why?
|
| Forkhead Transcription Factors | 7 | 2017 | 371 | 1.020 |
Why?
|
| Trans-Activators | 7 | 2016 | 805 | 1.020 |
Why?
|
| Mitochondria | 12 | 2021 | 684 | 0.910 |
Why?
|
| Cell Differentiation | 12 | 2020 | 1936 | 0.880 |
Why?
|
| Sirtuins | 5 | 2011 | 22 | 0.870 |
Why?
|
| Gluconeogenesis | 2 | 2022 | 107 | 0.800 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2022 | 48 | 0.800 |
Why?
|
| Sirtuin 2 | 5 | 2017 | 11 | 0.790 |
Why?
|
| Adipose Tissue, Brown | 7 | 2019 | 76 | 0.780 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 210 | 0.720 |
Why?
|
| Transcription Factors | 13 | 2023 | 2589 | 0.710 |
Why?
|
| Mice | 46 | 2022 | 17647 | 0.660 |
Why?
|
| DNA-Binding Proteins | 7 | 2023 | 2060 | 0.640 |
Why?
|
| GATA2 Transcription Factor | 8 | 2023 | 45 | 0.630 |
Why?
|
| Hepatocytes | 5 | 2022 | 257 | 0.630 |
Why?
|
| Oxidative Stress | 5 | 2022 | 804 | 0.620 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2020 | 166 | 0.590 |
Why?
|
| Cell Line | 14 | 2023 | 2787 | 0.580 |
Why?
|
| Sirtuin 1 | 4 | 2021 | 48 | 0.540 |
Why?
|
| Animals | 54 | 2022 | 33923 | 0.540 |
Why?
|
| Reactive Oxygen Species | 7 | 2021 | 483 | 0.540 |
Why?
|
| Insulin Resistance | 4 | 2021 | 635 | 0.500 |
Why?
|
| Caloric Restriction | 4 | 2010 | 72 | 0.500 |
Why?
|
| Adipose Tissue | 6 | 2021 | 446 | 0.480 |
Why?
|
| Mitochondrial Proteins | 7 | 2022 | 238 | 0.460 |
Why?
|
| Acetylation | 10 | 2022 | 166 | 0.450 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2008 | 558 | 0.450 |
Why?
|
| GATA3 Transcription Factor | 4 | 2007 | 39 | 0.440 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2011 | 279 | 0.430 |
Why?
|
| Multiple Myeloma | 3 | 2020 | 170 | 0.410 |
Why?
|
| PPAR gamma | 3 | 2019 | 92 | 0.410 |
Why?
|
| Adipogenesis | 5 | 2020 | 75 | 0.400 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 40 | 0.400 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2011 | 17 | 0.390 |
Why?
|
| Adipose Tissue, White | 2 | 2011 | 78 | 0.390 |
Why?
|
| Muscle, Skeletal | 3 | 2018 | 932 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 4392 | 0.370 |
Why?
|
| Promoter Regions, Genetic | 8 | 2019 | 1354 | 0.360 |
Why?
|
| Proteins | 5 | 2010 | 1045 | 0.350 |
Why?
|
| Lipolysis | 3 | 2019 | 82 | 0.340 |
Why?
|
| Body Composition | 3 | 2019 | 479 | 0.330 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2008 | 16 | 0.320 |
Why?
|
| Cytokines | 2 | 2012 | 1287 | 0.320 |
Why?
|
| Signal Transduction | 12 | 2019 | 4524 | 0.320 |
Why?
|
| Histone Deacetylases | 2 | 2010 | 115 | 0.320 |
Why?
|
| Physical Conditioning, Animal | 1 | 2009 | 92 | 0.310 |
Why?
|
| Adiponectin | 2 | 2006 | 109 | 0.310 |
Why?
|
| Thermogenesis | 3 | 2019 | 43 | 0.300 |
Why?
|
| Doxorubicin | 2 | 2022 | 307 | 0.290 |
Why?
|
| Aging | 3 | 2011 | 1175 | 0.290 |
Why?
|
| Reperfusion Injury | 2 | 2021 | 102 | 0.290 |
Why?
|
| Mice, Obese | 2 | 2022 | 77 | 0.280 |
Why?
|
| Forkhead Box Protein O1 | 4 | 2017 | 95 | 0.270 |
Why?
|
| Mammary Glands, Human | 1 | 2007 | 80 | 0.270 |
Why?
|
| 3T3 Cells | 5 | 2020 | 129 | 0.260 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 1998 | 133 | 0.260 |
Why?
|
| MicroRNAs | 2 | 2023 | 836 | 0.260 |
Why?
|
| Uncoupling Protein 1 | 3 | 2019 | 28 | 0.250 |
Why?
|
| Repressor Proteins | 2 | 2008 | 815 | 0.250 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 3299 | 0.250 |
Why?
|
| Cell Lineage | 1 | 2007 | 348 | 0.240 |
Why?
|
| HEK293 Cells | 6 | 2020 | 745 | 0.240 |
Why?
|
| Mice, Knockout | 12 | 2021 | 3782 | 0.240 |
Why?
|
| RNA, Messenger | 8 | 2023 | 2833 | 0.240 |
Why?
|
| Up-Regulation | 5 | 2019 | 874 | 0.230 |
Why?
|
| Protein Isoforms | 4 | 2018 | 410 | 0.220 |
Why?
|
| Malates | 1 | 2023 | 7 | 0.220 |
Why?
|
| RNA, Antisense | 1 | 2023 | 35 | 0.220 |
Why?
|
| Mammary Glands, Animal | 1 | 2007 | 482 | 0.220 |
Why?
|
| Aspartic Acid | 1 | 2023 | 75 | 0.220 |
Why?
|
| Obesity | 8 | 2021 | 2089 | 0.210 |
Why?
|
| Protein Binding | 7 | 2017 | 1738 | 0.210 |
Why?
|
| Lipid Droplets | 2 | 2020 | 46 | 0.210 |
Why?
|
| Niacinamide | 2 | 2021 | 24 | 0.210 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2023 | 240 | 0.210 |
Why?
|
| Diet | 1 | 2009 | 1112 | 0.200 |
Why?
|
| Ribosomes | 1 | 2023 | 138 | 0.200 |
Why?
|
| HIV-1 | 1 | 2006 | 464 | 0.200 |
Why?
|
| RNA-Binding Proteins | 2 | 2023 | 570 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 282 | 0.200 |
Why?
|
| Epithelial Cells | 1 | 2007 | 907 | 0.200 |
Why?
|
| Osteoblasts | 2 | 2020 | 151 | 0.200 |
Why?
|
| Drosophila Proteins | 6 | 1998 | 709 | 0.200 |
Why?
|
| Autophagy | 3 | 2020 | 390 | 0.200 |
Why?
|
| Oxygen Consumption | 3 | 2015 | 304 | 0.200 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 1283 | 0.190 |
Why?
|
| Humans | 36 | 2023 | 122853 | 0.190 |
Why?
|
| Berberine | 1 | 2021 | 10 | 0.190 |
Why?
|
| Proto-Oncogenes | 3 | 1998 | 37 | 0.190 |
Why?
|
| DNA Helicases | 1 | 2023 | 226 | 0.190 |
Why?
|
| Pyridinium Compounds | 1 | 2021 | 20 | 0.190 |
Why?
|
| Apoptosis | 3 | 2015 | 1792 | 0.190 |
Why?
|
| Mitochondria, Liver | 1 | 2021 | 33 | 0.190 |
Why?
|
| Carrier Proteins | 4 | 2005 | 1024 | 0.190 |
Why?
|
| Liver Regeneration | 1 | 2021 | 52 | 0.190 |
Why?
|
| Protein Stability | 2 | 2011 | 168 | 0.180 |
Why?
|
| Liver | 2 | 2022 | 1858 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2023 | 1885 | 0.180 |
Why?
|
| Blotting, Western | 6 | 2015 | 1106 | 0.180 |
Why?
|
| Cardiolipins | 2 | 2018 | 19 | 0.180 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 1997 | 197 | 0.180 |
Why?
|
| Ubiquitination | 2 | 2011 | 175 | 0.180 |
Why?
|
| Symporters | 2 | 1998 | 66 | 0.180 |
Why?
|
| Tripartite Motif Proteins | 1 | 2020 | 15 | 0.180 |
Why?
|
| Gene Expression Regulation | 5 | 2011 | 2541 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 214 | 0.180 |
Why?
|
| Lipid Mobilization | 1 | 2020 | 3 | 0.170 |
Why?
|
| Dynamins | 1 | 2020 | 40 | 0.170 |
Why?
|
| Mitochondria, Heart | 2 | 2022 | 60 | 0.170 |
Why?
|
| Forkhead Box Protein O3 | 2 | 2011 | 25 | 0.170 |
Why?
|
| Cell Communication | 1 | 2020 | 165 | 0.170 |
Why?
|
| NAD | 2 | 2009 | 50 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2023 | 2321 | 0.160 |
Why?
|
| Glucose | 2 | 2022 | 876 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 213 | 0.160 |
Why?
|
| Bone Diseases | 1 | 2019 | 45 | 0.160 |
Why?
|
| Lignans | 1 | 2018 | 4 | 0.160 |
Why?
|
| Cytoprotection | 1 | 2018 | 39 | 0.160 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2018 | 14 | 0.150 |
Why?
|
| Biphenyl Compounds | 1 | 2018 | 56 | 0.150 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2018 | 49 | 0.150 |
Why?
|
| Thyroid Neoplasms | 6 | 1998 | 193 | 0.150 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 538 | 0.150 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 116 | 0.150 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 19 | 0.150 |
Why?
|
| Fasting | 2 | 2009 | 299 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 351 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2019 | 319 | 0.140 |
Why?
|
| Leucine Zippers | 1 | 1997 | 17 | 0.140 |
Why?
|
| Membrane Proteins | 3 | 2005 | 1529 | 0.140 |
Why?
|
| Muscle Proteins | 1 | 2020 | 416 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 115 | 0.140 |
Why?
|
| Male | 19 | 2021 | 59866 | 0.140 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 37 | 0.140 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 69 | 0.140 |
Why?
|
| Carcinoma, Papillary | 5 | 1998 | 76 | 0.140 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 206 | 0.140 |
Why?
|
| Glycoproteins | 2 | 2018 | 372 | 0.130 |
Why?
|
| Rats | 7 | 2022 | 3665 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 114 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2018 | 339 | 0.130 |
Why?
|
| Phosphorylation | 4 | 2017 | 1617 | 0.120 |
Why?
|
| 3T3-L1 Cells | 2 | 2020 | 56 | 0.120 |
Why?
|
| Lysine | 2 | 2017 | 200 | 0.120 |
Why?
|
| HIV Infections | 2 | 2006 | 1862 | 0.120 |
Why?
|
| Sex Characteristics | 3 | 2021 | 309 | 0.120 |
Why?
|
| Myocytes, Cardiac | 2 | 2022 | 618 | 0.120 |
Why?
|
| Oncogene Proteins | 1 | 1995 | 140 | 0.120 |
Why?
|
| Molecular Sequence Data | 8 | 2010 | 3888 | 0.120 |
Why?
|
| Mice, Transgenic | 6 | 2022 | 2443 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 129 | 0.110 |
Why?
|
| Hedgehog Proteins | 1 | 2015 | 192 | 0.110 |
Why?
|
| Transcriptional Activation | 2 | 2023 | 483 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2017 | 1302 | 0.110 |
Why?
|
| Kidney | 1 | 2021 | 1346 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 354 | 0.110 |
Why?
|
| Citrate (si)-Synthase | 2 | 2014 | 19 | 0.110 |
Why?
|
| Transfection | 4 | 2011 | 1076 | 0.110 |
Why?
|
| Endometrium | 1 | 2016 | 276 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 516 | 0.110 |
Why?
|
| Progesterone | 1 | 2016 | 624 | 0.110 |
Why?
|
| Lipid Metabolism | 4 | 2020 | 354 | 0.110 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2013 | 54 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 664 | 0.110 |
Why?
|
| Thyroid Gland | 5 | 1998 | 117 | 0.110 |
Why?
|
| Insulin | 2 | 2012 | 1196 | 0.110 |
Why?
|
| Ion Channels | 3 | 2014 | 187 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2013 | 131 | 0.100 |
Why?
|
| Camptothecin | 1 | 2013 | 78 | 0.100 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2013 | 90 | 0.100 |
Why?
|
| Enzyme Activation | 3 | 2020 | 621 | 0.100 |
Why?
|
| Deoxyglucose | 1 | 2012 | 30 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 102 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2009 | 773 | 0.100 |
Why?
|
| Receptors, Ghrelin | 1 | 2011 | 28 | 0.100 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 32 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 115 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2013 | 230 | 0.100 |
Why?
|
| Half-Life | 1 | 2011 | 157 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 342 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 714 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 238 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2009 | 46 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 516 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 98 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2009 | 110 | 0.090 |
Why?
|
| Gene Expression | 5 | 2000 | 1592 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2013 | 619 | 0.090 |
Why?
|
| Succinate Dehydrogenase | 1 | 2010 | 7 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2017 | 670 | 0.090 |
Why?
|
| Base Sequence | 5 | 2016 | 3118 | 0.090 |
Why?
|
| Animal Structures | 1 | 2009 | 8 | 0.080 |
Why?
|
| Models, Animal | 3 | 2019 | 467 | 0.080 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 73 | 0.080 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2009 | 40 | 0.080 |
Why?
|
| Protein Transport | 1 | 2010 | 369 | 0.080 |
Why?
|
| Longevity | 1 | 2010 | 120 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 64 | 0.080 |
Why?
|
| RNA Interference | 2 | 2009 | 497 | 0.080 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2009 | 15 | 0.080 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 207 | 0.080 |
Why?
|
| Cold Temperature | 1 | 2008 | 81 | 0.080 |
Why?
|
| Isoproterenol | 1 | 2008 | 105 | 0.080 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 98 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-ret | 6 | 1998 | 29 | 0.080 |
Why?
|
| Homeostasis | 3 | 2013 | 682 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 297 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 392 | 0.070 |
Why?
|
| Superoxides | 2 | 2021 | 154 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2017 | 808 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 607 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3075 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 1009 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2009 | 220 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2007 | 49 | 0.070 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2007 | 77 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 444 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2020 | 572 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1997 | 213 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 966 | 0.070 |
Why?
|
| Receptors, HIV | 1 | 2006 | 3 | 0.070 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 28 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 2702 | 0.070 |
Why?
|
| Methylation | 2 | 2019 | 227 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 1007 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 1998 | 1067 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2005 | 382 | 0.060 |
Why?
|
| Oncogenes | 2 | 1997 | 172 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2018 | 460 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2006 | 236 | 0.060 |
Why?
|
| Cell Respiration | 1 | 2005 | 24 | 0.060 |
Why?
|
| ADP Ribose Transferases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 1703 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 326 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2017 | 1468 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 266 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2006 | 395 | 0.060 |
Why?
|
| Temperature | 1 | 2005 | 304 | 0.060 |
Why?
|
| Brain | 2 | 2018 | 2961 | 0.060 |
Why?
|
| Glycosylation | 1 | 2023 | 113 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 207 | 0.060 |
Why?
|
| DNA Primers | 3 | 2010 | 669 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 672 | 0.050 |
Why?
|
| Neurons | 1 | 2013 | 1933 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 474 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2003 | 96 | 0.050 |
Why?
|
| Histones | 2 | 2019 | 528 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 171 | 0.050 |
Why?
|
| Female | 9 | 2021 | 65278 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 203 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2010 | 835 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1216 | 0.050 |
Why?
|
| Hormones, Ectopic | 1 | 2001 | 10 | 0.050 |
Why?
|
| DNA | 2 | 2005 | 1608 | 0.050 |
Why?
|
| RNA | 1 | 2005 | 577 | 0.050 |
Why?
|
| Tyrosine | 2 | 2001 | 166 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2001 | 80 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2019 | 702 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2000 | 114 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2020 | 46 | 0.040 |
Why?
|
| Thyrotropin | 2 | 1997 | 58 | 0.040 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2019 | 9 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2015 | 1073 | 0.040 |
Why?
|
| Luciferases | 2 | 2013 | 137 | 0.040 |
Why?
|
| Carbon-Carbon Double Bond Isomerases | 1 | 2019 | 1 | 0.040 |
Why?
|
| Adrenergic beta-3 Receptor Antagonists | 1 | 2019 | 1 | 0.040 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 2019 | 2 | 0.040 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2019 | 10 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 9 | 0.040 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 6 | 0.040 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Racemases and Epimerases | 1 | 2019 | 10 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2019 | 43 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2019 | 41 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 57 | 0.040 |
Why?
|
| Adipokines | 1 | 2019 | 58 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 93 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 78 | 0.040 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 1 | 2018 | 4 | 0.040 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2018 | 8 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 301 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 534 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 36 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 197 | 0.040 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2018 | 38 | 0.040 |
Why?
|
| Electron Transport | 1 | 2018 | 54 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2018 | 31 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2019 | 154 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 33 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 1995 | 138 | 0.040 |
Why?
|
| Receptors, Thyrotropin | 1 | 1997 | 11 | 0.040 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 1997 | 15 | 0.040 |
Why?
|
| PAX8 Transcription Factor | 1 | 1997 | 15 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2019 | 354 | 0.040 |
Why?
|
| Proteinuria | 1 | 2018 | 110 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 2017 | 30 | 0.040 |
Why?
|
| Paired Box Transcription Factors | 1 | 1997 | 75 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 92 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4308 | 0.040 |
Why?
|
| Phospholipids | 1 | 2018 | 107 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2019 | 330 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 92 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2017 | 6 | 0.040 |
Why?
|
| Thyroglobulin | 1 | 1997 | 7 | 0.040 |
Why?
|
| Neuroprotection | 1 | 2017 | 19 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 198 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2017 | 312 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2017 | 29 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 317 | 0.030 |
Why?
|
| COS Cells | 1 | 1997 | 273 | 0.030 |
Why?
|
| Dopaminergic Neurons | 1 | 2017 | 49 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 141 | 0.030 |
Why?
|
| Mutation | 3 | 2017 | 5794 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2010 | 1069 | 0.030 |
Why?
|
| Body Height | 1 | 2017 | 205 | 0.030 |
Why?
|
| Myopia | 1 | 2018 | 193 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 462 | 0.030 |
Why?
|
| Lactation | 1 | 2017 | 186 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2016 | 293 | 0.030 |
Why?
|
| Binding Sites | 3 | 2009 | 1294 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 351 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2017 | 215 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1996 | 65 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 334 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 477 | 0.030 |
Why?
|
| Stem Cells | 1 | 2000 | 713 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 461 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2015 | 27 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 186 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 234 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2014 | 15 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 2483 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 402 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 2016 | 230 | 0.030 |
Why?
|
| Cilia | 1 | 2015 | 73 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1997 | 547 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 141 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 262 | 0.030 |
Why?
|
| Mothers | 1 | 2017 | 348 | 0.030 |
Why?
|
| COUP Transcription Factor II | 1 | 2015 | 117 | 0.030 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2014 | 6 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 7126 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1400 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1996 | 762 | 0.030 |
Why?
|
| Mitochondria, Muscle | 1 | 2014 | 34 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 261 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 113 | 0.030 |
Why?
|
| Genetic Markers | 1 | 1996 | 597 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 261 | 0.030 |
Why?
|
| Physical Exertion | 1 | 2014 | 80 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 449 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 1995 | 270 | 0.030 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 1 | 2013 | 12 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 816 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 468 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2017 | 462 | 0.030 |
Why?
|
| Cattle | 2 | 2009 | 559 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 799 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 528 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1998 | 677 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 29 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2014 | 72 | 0.030 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2013 | 5 | 0.030 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 383 | 0.030 |
Why?
|
| Taurine | 1 | 1993 | 12 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 1108 | 0.030 |
Why?
|
| Introns | 2 | 2009 | 302 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 128 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 880 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 84 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 865 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1994 | 346 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 240 | 0.030 |
Why?
|
| Mitosis | 1 | 2013 | 240 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2009 | 623 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 153 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 1993 | 176 | 0.020 |
Why?
|
| Ghrelin | 1 | 2011 | 47 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 1760 | 0.020 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2010 | 16 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 415 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 492 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1598 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 811 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2015 | 482 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 181 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 66 | 0.020 |
Why?
|
| DNA Damage | 1 | 2013 | 517 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 43 | 0.020 |
Why?
|
| Chromatin | 1 | 2013 | 553 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 632 | 0.020 |
Why?
|
| Eating | 1 | 2011 | 355 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 1158 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 107 | 0.020 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2009 | 10 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2009 | 31 | 0.020 |
Why?
|
| Heart Failure | 1 | 2022 | 2125 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2010 | 288 | 0.020 |
Why?
|
| Granulocytes | 1 | 2009 | 65 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2010 | 209 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 721 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 307 | 0.020 |
Why?
|
| Point Mutation | 1 | 2009 | 347 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 355 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2011 | 748 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 799 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1682 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 745 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 260 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 402 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 1996 | 303 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8120 | 0.010 |
Why?
|
| Benzophenones | 1 | 2001 | 6 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2001 | 24 | 0.010 |
Why?
|
| Resistin | 1 | 2001 | 36 | 0.010 |
Why?
|
| Thiazoles | 1 | 2001 | 96 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 3083 | 0.010 |
Why?
|
| Iodides | 1 | 1998 | 16 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1998 | 190 | 0.010 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 1998 | 3 | 0.010 |
Why?
|
| Receptor, EphB4 | 1 | 1998 | 3 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1998 | 28 | 0.010 |
Why?
|
| Receptors, Eph Family | 1 | 1998 | 21 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 167 | 0.010 |
Why?
|
| Hirschsprung Disease | 1 | 1998 | 37 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2001 | 419 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1998 | 112 | 0.010 |
Why?
|
| Iodine | 1 | 1997 | 24 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1997 | 63 | 0.010 |
Why?
|
| Thyroxine | 1 | 1997 | 65 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1997 | 84 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1997 | 215 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 125 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 40 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 1996 | 76 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 668 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1404 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 441 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 465 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 353 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1993 | 247 | 0.010 |
Why?
|
| Biological Transport | 1 | 1993 | 347 | 0.010 |
Why?
|
| Species Specificity | 1 | 1993 | 552 | 0.010 |
Why?
|
| Exons | 1 | 1994 | 795 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 900 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 969 | 0.010 |
Why?
|
| Cell Division | 1 | 1993 | 793 | 0.010 |
Why?
|
| Time Factors | 1 | 1997 | 6202 | 0.000 |
Why?
|